{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:14:59Z","timestamp":1790525699650,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T00:00:00Z","timestamp":1444953600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12672-015-0236-z","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:19:47Z","timestamp":1445213987000},"page":"225-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors"],"prefix":"10.1007","volume":"6","author":[{"given":"Dorothee","family":"Heck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luitgard","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina L.","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard O.","family":"Sinnott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silviu","family":"Sbiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,16]]},"reference":[{"issue":"11","key":"236_CR1","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2001-011799","volume":"87","author":"GP Bernini","year":"2002","unstructured":"Bernini GP, Moretti A, Bonadio AG, Menicagli M, Viacava P, Naccarato AG, Iacconi P, Miccoli P, Salvetti A (2002) Angiogenesis in human normal and pathologic adrenal cortex. J Clin Endocrinol Metab 87(11):4961\u20134965. doi: 10.1210\/jc.2001-011799","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 7","key":"236_CR2","doi-asserted-by":"crossref","first-page":"vii131","DOI":"10.1093\/annonc\/mds231","volume":"23","author":"A Berruti","year":"2012","unstructured":"Berruti A, Baudin E, Gelderblom H, Haak HR, Porpiglia F, Fassnacht M, Pentheroudakis G (2012) Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii131\u2013138. doi: 10.1093\/annonc\/mds231","journal-title":"Ann Oncol"},{"issue":"3","key":"236_CR3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","volume":"100","author":"F Beuschlein","year":"2015","unstructured":"Beuschlein F, Weigel J, Saeger W, Kroiss M, Wild V, Daffara F, Libe R et al (2015) Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab 100(3):841\u2013849. doi: 10.1210\/jc.2014-3182","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 10","key":"236_CR4","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1242\/jcs.062661","volume":"123","author":"BG Bitler","year":"2010","unstructured":"Bitler BG, Goverdhan A, Schroeder JA (2010) MUC1 regulates nuclear localization and function of the epidermal growth factor receptor. J Cell Sci 123(Pt 10):1716\u20131723. doi: 10.1242\/jcs.062661","journal-title":"J Cell Sci"},{"issue":"9940","key":"236_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","volume":"384","author":"MS Brose","year":"2014","unstructured":"Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C et al (2014) Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet 384(9940):319\u2013328. doi: 10.1016\/s0140-6736(14)60421-9","journal-title":"Lancet"},{"issue":"7070","key":"236_CR6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438(7070):932\u2013936. doi: 10.1038\/nature04478","journal-title":"Nature"},{"issue":"7070","key":"236_CR7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature04479","volume":"438","author":"L Coultas","year":"2005","unstructured":"Coultas L, Chawengsaksophak K, Rossant J (2005) Endothelial cells and VEGF in vascular development. Nature 438(7070):937\u2013945. doi: 10.1038\/nature04479","journal-title":"Nature"},{"issue":"12","key":"236_CR8","first-page":"4734","volume":"85","author":"F Fraipont de","year":"2000","unstructured":"de Fraipont F, El Atifi M, Gicquel C, Bertagna X, Chambaz EM, Feige JJ (2000) Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations. J Clin Endocrinol Metab 85(12):4734\u20134741. doi: 10.1210\/jcem.85.12.7012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"236_CR9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.humpath.2012.07.025","volume":"44","author":"E Duregon","year":"2013","unstructured":"Duregon E, Volante M, Giorcelli J, Terzolo M, Lalli E, Papotti M (2013) Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates. Hum Pathol 44(5):822\u2013828. doi: 10.1016\/j.humpath.2012.07.025","journal-title":"Hum Pathol"},{"issue":"29","key":"236_CR10","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","volume":"31","author":"R Elisei","year":"2013","unstructured":"Elisei R, Schlumberger MJ, Muller SP, Schoffski P, Brose MS, Shah MH, Licitra L et al (2013) Cabozantinib in progressive medullary thyroid cancer. J Clin Oncol 31(29):3639\u20133646. doi: 10.1200\/jco.2012.48.4659","journal-title":"J Clin Oncol"},{"issue":"2","key":"236_CR11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD (2014) Adrenocortical carcinoma. Endocr Rev 35(2):282\u2013326. doi: 10.1210\/er.2013-1029","journal-title":"Endocr Rev"},{"issue":"2","key":"236_CR12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","volume":"115","author":"M Fassnacht","year":"2009","unstructured":"Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B (2009) Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 115(2):243\u2013250. doi: 10.1002\/cncr.24030","journal-title":"Cancer"},{"issue":"12","key":"236_CR13","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","volume":"98","author":"M Fassnacht","year":"2013","unstructured":"Fassnacht M, Kroiss M, Allolio B (2013) Update in adrenocortical carcinoma. J Clin Endocrinol Metab 98(12):4551\u20134564. doi: 10.1210\/jc.2013-3020","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"236_CR14","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","volume":"366","author":"M Fassnacht","year":"2012","unstructured":"Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S et al (2012) Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med 366(23):2189\u20132197. doi: 10.1056\/NEJMoa1200966","journal-title":"N Engl J Med"},{"key":"236_CR15","author":"AP Fay","year":"2014","unstructured":"Fay AP, Elfiky A, Telo GH, McKay RR, Kaymakcalan M, Nguyen PL, Vaidya A, Ruan DT, Bellmunt J, Choueiri TK (2014) Adrenocortical carcinoma: the management of metastatic disease. Crit Rev Oncol Hematol. doi: 10.1016\/j.critrevonc.2014.05.009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"236_CR16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/bbrc.1998.9790","volume":"256","author":"Y Feng","year":"1999","unstructured":"Feng Y, Venema VJ, Venema RC, Tsai N, Caldwell RB (1999) VEGF induces nuclear translocation of Flk-1\/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun 256(1):192\u2013197. doi: 10.1006\/bbrc.1998.9790","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"236_CR17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1677\/ERC-08-0211","volume":"16","author":"W Fenske","year":"2009","unstructured":"Fenske W, Volker HU, Adam P, Hahner S, Johanssen S, Wortmann S, Schmidt M et al (2009) Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma. Endocr Relat Cancer 16(3):919\u2013928. doi: 10.1677\/erc-08-0211","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"236_CR18","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0002-9440(10)64322-2","volume":"162","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Frantz G, LeCouter J, Dillard-Telm L, Pham T, Draksharapu A, Giordano T, Peale F (2003) Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol 162(6):1881\u20131893. doi: 10.1016\/S0002-9440(10)64322-2","journal-title":"Am J Pathol"},{"issue":"7070","key":"236_CR19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","volume":"438","author":"N Ferrara","year":"2005","unstructured":"Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438(7070):967\u2013974. doi: 10.1038\/nature04483","journal-title":"Nature"},{"issue":"1","key":"236_CR20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1210\/jc.2004-0843","volume":"90","author":"HM Fraser","year":"2005","unstructured":"Fraser HM, Bell J, Wilson H, Taylor PD, Morgan K, Anderson RA, Duncan WC (2005) Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum. J Clin Endocrinol Metab 90(1):427\u2013434. doi: 10.1210\/jc.2004-0843","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"236_CR21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1084\/jem.136.2.261","volume":"136","author":"MA Gimbrone Jr","year":"1972","unstructured":"Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J (1972) Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136(2):261\u2013276","journal-title":"J Exp Med"},{"issue":"6","key":"236_CR22","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/0008-5472.CAN-3696-2","volume":"64","author":"T Goi","year":"2004","unstructured":"Goi T, Fujioka M, Satoh Y, Tabata S, Koneri K, Nagano H, Hirono Y, Katayama K, Hirose K, Yamaguchi A (2004) Angiogenesis and tumor proliferation\/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res 64(6):1906\u20131910","journal-title":"Cancer Res"},{"issue":"12","key":"236_CR23","first-page":"5311","volume":"33","author":"T Goi","year":"2013","unstructured":"Goi T, Nakazawa T, Hirono Y, Yamaguchi A (2013) Prokineticin 1 expression in gastrointestinal tumors. Anticancer Res 33(12):5311\u20135315","journal-title":"Anticancer Res"},{"issue":"5","key":"236_CR24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1745-7270.2008.00418.x","volume":"40","author":"Y Guo","year":"2008","unstructured":"Guo Y, Xiao P, Lei S, Deng F, Xiao GG, Liu Y, Chen X et al (2008) How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) 40(5):426\u2013436","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"6","key":"236_CR25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1530\/EJE-07-0723","volume":"158","author":"IG Hermsen","year":"2008","unstructured":"Hermsen IG, Gelderblom H, Kievit J, Romijn JA, Haak HR (2008) Extremely long survival in six patients despite recurrent and metastatic adrenal carcinoma. Eur J Endocrinol 158(6):911\u2013919. doi: 10.1530\/eje-07-0723","journal-title":"Eur J Endocrinol"},{"issue":"23","key":"236_CR26","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23):2335\u20132342. doi: 10.1056\/NEJMoa032691","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"236_CR27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000178888","volume":"9","author":"X Jiang","year":"2009","unstructured":"Jiang X, Abiatari I, Kong B, Erkan M, De Oliveira T, Giese NA, Michalski CW, Friess H, Kleeff J (2009) Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor\/prokineticin-1 in pancreatic cancer. Pancreatology 9(1\u20132):165\u2013172. doi: 10.1159\/000178888","journal-title":"Pancreatology"},{"issue":"3","key":"236_CR28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1677\/JOE-07-0255","volume":"196","author":"M Keramidas","year":"2008","unstructured":"Keramidas M, Faudot C, Cibiel A, Feige JJ, Thomas M (2008) Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells. J Endocrinol 196(3):473\u2013482. doi: 10.1677\/JOE-07-0255","journal-title":"J Endocrinol"},{"key":"236_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fendo.2011.00027","volume":"2","author":"M Kroiss","year":"2011","unstructured":"Kroiss M, Reuss M, Kuhner D, Johanssen S, Beyer M, Zink M, Hartmann MF et al (2011) Sunitinib inhibits cell proliferation and alters steroidogenesis by down-regulation of HSD3B2 in adrenocortical carcinoma cells. Front Endocrinol (Lausanne) 2:27. doi: 10.3389\/fendo.2011.00027","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"236_CR30","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/bjc.2014.20","volume":"110","author":"S Lauttia","year":"2014","unstructured":"Lauttia S, Sihto H, Kavola H, Koljonen V, Bohling T, Joensuu H (2014) Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma. Br J Cancer 110(6):1446\u20131455. doi: 10.1038\/bjc.2014.20","journal-title":"Br J Cancer"},{"issue":"6850","key":"236_CR31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/35091000","volume":"412","author":"J LeCouter","year":"2001","unstructured":"LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G et al (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412(6850):877\u2013884. doi: 10.1038\/35091000","journal-title":"Nature"},{"issue":"6","key":"236_CR32","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1210\/en.2002-0146","volume":"144","author":"J LeCouter","year":"2003","unstructured":"LeCouter J, Lin R, Frantz G, Zhang Z, Hillan K, Ferrara N (2003) Mouse endocrine gland-derived vascular endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis. Endocrinology 144(6):2606\u20132616. doi: 10.1210\/en.2002-0146","journal-title":"Endocrinology"},{"issue":"4","key":"236_CR33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/mol.59.4.692","volume":"59","author":"M Li","year":"2001","unstructured":"Li M, Bullock CM, Knauer DJ, Ehlert FJ, Zhou QY (2001) Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 59(4):692\u2013698","journal-title":"Mol Pharmacol"},{"issue":"10","key":"236_CR34","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3109\/10428194.2010.512963","volume":"51","author":"QF Li","year":"2010","unstructured":"Li QF, Zhu HY, Yang YF, Liu J, Xiao FJ, Zhang QW, Wu CT, Wang H, Wang LS (2010) Prokineticin-1\/endocrine gland-derived vascular endothelial growth factor is a survival factor for human multiple myeloma cells. Leuk Lymphoma 51(10):1902\u20131912. doi: 10.3109\/10428194.2010.512963","journal-title":"Leuk Lymphoma"},{"issue":"22","key":"236_CR35","doi-asserted-by":"crossref","first-page":"19276","DOI":"10.1074\/jbc.M202139200","volume":"277","author":"DC Lin","year":"2002","unstructured":"Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY (2002) Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins\/endocrine gland vascular endothelial growth factor. J Biol Chem 277(22):19276\u201319280. doi: 10.1074\/jbc.M202139200","journal-title":"J Biol Chem"},{"issue":"10","key":"236_CR36","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1074\/jbc.M110594200","volume":"277","author":"R Lin","year":"2002","unstructured":"Lin R, LeCouter J, Kowalski J, Ferrara N (2002) Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J Biol Chem 277(10):8724\u20138729. doi: 10.1074\/jbc.M110594200","journal-title":"J Biol Chem"},{"issue":"2","key":"236_CR37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1083\/jcb.134.2.529","volume":"134","author":"PA Maher","year":"1996","unstructured":"Maher PA (1996) Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J Cell Biol 134(2):529\u2013536","journal-title":"J Cell Biol"},{"issue":"1","key":"236_CR38","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0006-291X(02)00239-5","volume":"293","author":"Y Masuda","year":"2002","unstructured":"Masuda Y, Takatsu Y, Terao Y, Kumano S, Ishibashi Y, Suenaga M, Abe M et al (2002) Isolation and identification of EG-VEGF\/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem Biophys Res Commun 293(1):396\u2013402. doi: 10.1016\/S0006-291X(02)00239-5","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"236_CR39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsbmb.2007.02.006","volume":"107","author":"A Morales","year":"2007","unstructured":"Morales A, Vilchis F, Chavez B, Chan C, Robles-Diaz G, Diaz-Sanchez V (2007) Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma. J Steroid Biochem Mol Biol 107(1\u20132):37\u201341. doi: 10.1016\/j.jsbmb.2007.02.006","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"236_CR40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2005.02.2574","volume":"24","author":"RJ Motzer","year":"2006","unstructured":"Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS et al (2006) Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24(1):16\u201324. doi: 10.1200\/jco.2005.02.2574","journal-title":"J Clin Oncol"},{"issue":"7","key":"236_CR41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jso.20716","volume":"96","author":"H Nagano","year":"2007","unstructured":"Nagano H, Goi T, Koneri K, Hirono Y, Katayama K, Yamaguchi A (2007) Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) expression in colorectal cancer. J Surg Oncol 96(7):605\u2013610. doi: 10.1002\/jso.20716","journal-title":"J Surg Oncol"},{"issue":"3","key":"236_CR42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1113\/jphysiol.1912.sp001546","volume":"45","author":"KO Neuman","year":"1912","unstructured":"Neuman KO (1912) The oxygen exchange of the suprarenal gland. J Physiol 45(3):188\u2013196","journal-title":"J Physiol"},{"issue":"1","key":"236_CR43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/en.2005-0543","volume":"147","author":"ES Ngan","year":"2006","unstructured":"Ngan ES, Lee KY, Yeung WS, Ngan HY, Ng EH, Ho PC (2006) Endocrine gland-derived vascular endothelial growth factor is expressed in human peri-implantation endometrium, but not in endometrial carcinoma. Endocrinology 147(1):88\u201395. doi: 10.1210\/en.2005-0543","journal-title":"Endocrinology"},{"issue":"3","key":"236_CR44","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1078-0432.CCR-06-2176","volume":"13","author":"ES Ngan","year":"2007","unstructured":"Ngan ES, Sit FY, Lee K, Miao X, Yuan Z, Wang W, Nicholls JM et al (2007) Implications of endocrine gland-derived vascular endothelial growth factor\/prokineticin-1 signaling in human neuroblastoma progression. Clin Cancer Res 13(3):868\u2013875. doi: 10.1158\/1078-0432.CCR-06-2176","journal-title":"Clin Cancer Res"},{"issue":"10","key":"236_CR45","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","volume":"355","author":"KA Olaussen","year":"2006","unstructured":"Olaussen KA, Dunant A, Fouret P, Brambilla E, Andre F, Haddad V, Taranchon E et al (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355(10):983\u2013991. doi: 10.1056\/NEJMoa060570","journal-title":"N Engl J Med"},{"issue":"9","key":"236_CR46","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1210\/en.2006-0614","volume":"147","author":"D Pasquali","year":"2006","unstructured":"Pasquali D, Rossi V, Staibano S, De Rosa G, Chieffi P, Prezioso D, Mirone V et al (2006) The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)\/prokineticin 1 and 2 and receptor expression in human prostate: up-regulation of EG-VEGF\/prokineticin 1 with malignancy. Endocrinology 147(9):4245\u20134251. doi: 10.1210\/en.2006-0614","journal-title":"Endocrinology"},{"issue":"4","key":"236_CR47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/thy.2010.0168","volume":"21","author":"D Pasquali","year":"2011","unstructured":"Pasquali D, Santoro A, Bufo P, Conzo G, Deery WJ, Renzullo A, Accardo G, Sacco V, Bellastella A, Pannone G (2011) Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation. Thyroid 21(4):391\u2013399. doi: 10.1089\/thy.2010.0168","journal-title":"Thyroid"},{"issue":"6","key":"236_CR48","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","volume":"364","author":"E Raymond","year":"2011","unstructured":"Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J et al (2011) Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 364(6):501\u2013513. doi: 10.1056\/NEJMoa1003825","journal-title":"N Engl J Med"},{"issue":"1","key":"236_CR49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbrc.2009.05.149","volume":"386","author":"LN Ren","year":"2009","unstructured":"Ren LN, Li QF, Xiao FJ, Yan J, Yang YF, Wang LS, Guo XZ, Wang H (2009) Endocrine glands-derived vascular endothelial growth factor protects pancreatic cancer cells from apoptosis via upregulation of the myeloid cell leukemia-1 protein. Biochem Biophys Res Commun 386(1):35\u201339. doi: 10.1016\/j.bbrc.2009.05.149","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"236_CR50","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1677\/ERC-08-0224","volume":"16","author":"CL Ronchi","year":"2009","unstructured":"Ronchi CL, Sbiera S, Kraus L, Wortmann S, Johanssen S, Adam P, Willenberg HS, Hahner S, Allolio B, Fassnacht M (2009) Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy. Endocr Relat Cancer 16(3):907\u2013918. doi: 10.1677\/ERC-08-0224","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"236_CR51","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jc.2003-032024","volume":"89","author":"M Samson","year":"2004","unstructured":"Samson M, Peale FV Jr, Frantz G, Rioux-Leclercq N, Rajpert-De Meyts E, Ferrara N (2004) Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J Clin Endocrinol Metab 89(8):4078\u20134088. doi: 10.1210\/jc.2003-032024","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"236_CR52","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0653","volume":"95","author":"S Sbiera","year":"2010","unstructured":"Sbiera S, Schmull S, Assie G, Voelker HU, Kraus L, Beyer M, Ragazzon B et al (2010) High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. J Clin Endocrinol Metab 95(10):E161\u2013171. doi: 10.1210\/jc.2010-0653","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"236_CR53","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1158\/1078-0432.CCR-09-1587","volume":"15","author":"PS Soon","year":"2009","unstructured":"Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, Yeh MW et al (2009) miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin Cancer Res 15(24):7684\u20137692. doi: 10.1158\/1078-0432.ccr-09-1587","journal-title":"Clin Cancer Res"},{"issue":"1","key":"236_CR54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1152\/ajplegacy.1917.45.1.92","volume":"45","author":"GN Stewart","year":"1917","unstructured":"Stewart GN (1917) A note on some obvious consequences of the high rate of blood flow through the adrenals. Am J Physiol 45(1):92\u201395","journal-title":"Am J Physiol"},{"issue":"2","key":"236_CR55","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3892\/or.2012.2124","volume":"29","author":"S Tabata","year":"2013","unstructured":"Tabata S, Goi T, Nakazawa T, Kimura Y, Katayama K, Yamaguchi A (2013) Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines. Oncol Rep 29(2):459\u2013463. doi: 10.3892\/or.2012.2124","journal-title":"Oncol Rep"},{"issue":"23","key":"236_CR56","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","volume":"356","author":"M Terzolo","year":"2007","unstructured":"Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R et al (2007) Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 356(23):2372\u20132380. doi: 10.1056\/NEJMoa063360","journal-title":"N Engl J Med"},{"issue":"3","key":"236_CR57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jemt.10333","volume":"61","author":"M Thomas","year":"2003","unstructured":"Thomas M, Keramidas M, Monchaux E, Feige JJ (2003) Role of adrenocorticotropic hormone in the development and maintenance of the adrenal cortical vasculature. Microsc Res Tech 61(3):247\u2013251. doi: 10.1002\/jemt.10333","journal-title":"Microsc Res Tech"},{"issue":"5","key":"236_CR58","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2559.2009.03423.x","volume":"55","author":"M Volante","year":"2009","unstructured":"Volante M, Bollito E, Sperone P, Tavaglione V, Daffara F, Porpiglia F, Terzolo M, Berruti A, Papotti M (2009) Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. Histopathology 55(5):535\u2013543. doi: 10.1111\/j.1365-2559.2009.03423.x","journal-title":"Histopathology"},{"issue":"2","key":"236_CR59","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","volume":"30","author":"SA Wells Jr","year":"2012","unstructured":"Wells SA Jr, Robinson BG, Gagel RF, Dralle H, Fagin JA, Santoro M, Baudin E et al (2012) Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J Clin Oncol 30(2):134\u2013141. doi: 10.1200\/jco.2011.35.5040","journal-title":"J Clin Oncol"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-015-0236-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-015-0236-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-015-0236-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T17:41:03Z","timestamp":1567273263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-015-0236-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,16]]},"references-count":59,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1007\/s12672-015-0236-z","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,16]]}}}